会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Method and system of multi-pass iterative closest point (ICP) registration in automated facial reconstruction
    • US11854156B2
    • 2023-12-26
    • US17557446
    • 2021-12-21
    • Mathew PowersXiao XiaoWilliam A. Kennedy
    • Mathew PowersXiao XiaoWilliam A. Kennedy
    • G06T19/20G06T5/20G06V40/16G06T11/60
    • G06T19/20G06T5/20G06T11/60G06V40/165G06V40/171
    • In one aspect, a computerized method for implementing a multi-pass iterative closest point (ICP) registration in an automated facial reconstruction process includes the step of providing an automated facial reconstruction process. The method includes the step of detecting that a face tracking application programming interface (API) misalignment has occurred during the automated facial reconstruction process. The method includes the step of implementing a multi-pass ICP process on the face tracking API misalignment by the following steps. One step includes obtaining a first point cloud (PC1) of the automated facial reconstruction process. The method includes the step of obtaining a second point cloud (PC2) of the automated facial reconstruction process. The method includes the step of obtaining a first face mask (mask1) of the automated facial reconstruction process. The method includes the step of obtaining a second face mask (mask2) of the automated facial reconstruction process. The method includes the step of performing a first point cloud (PC1)-to-mask ICP operation by inputting and utilizing PC1 and mask1. A transformation output of the first PC-to-mask ICP operation is provided to a third PC-to-PC ICP and a fourth PC-to-PC ICP. The method includes the step of performing a second PC-to-mask ICP on PC2 and mask2. A transformation output of the second PC-to-mask ICP step is provided to a second PC-to-PC ICP and to the third PC-to-PC ICP. The method includes the step of performing a first PC-to-PC ICP on the PC1 and the PC2. The first PC-to-PC ICP outputs a first transformation of the first PC-to-PC ICP and a first error value of the first PC-to-PC ICP. The method includes the step of performing a second PC-to-PC ICP on the transformation output by the second PC-to-mask ICP and the PC1. The second PC-to-PC ICP outputs a second transformation of the second PC-to-PC ICP and a second error value of the second PC-to-PC ICP. The method includes the step of performing a third PC-to-PC ICP on the transformation output of the first PC-to-mask ICP and the transformation output of the second PC-to-mask ICP. The third PC-to-PC ICP outputs a third transformation of the third PC-to-PC ICP and a third error value of the third PC-to-PC ICP. The method includes the step of performing a fourth PC-to-PC ICP on the transformation output of the first PC-to-mask ICP and the PC2. The fourth PC-to-PC ICP outputs a fourth transformation of the fourth PC-to-PC ICP and a fourth error value of the fourth PC-to-PC ICP.
    • 10. 发明授权
    • Methods for increasing the efficiency of recombinant AAV product
    • 提高重组AAV产品效率的方法
    • US06548286B1
    • 2003-04-15
    • US09060102
    • 1998-04-14
    • Richard Jude SamulskiXiao XiaoRichard Snyder
    • Richard Jude SamulskiXiao XiaoRichard Snyder
    • C12N701
    • C12N15/86A61K48/00C07K14/005C12N7/00C12N2710/10322C12N2710/10343C12N2750/14121C12N2750/14122C12N2750/14143C12N2750/14152
    • The present invention relates to methods and compositions for increasing the production of high titre stocks of recombinant AAV (rAAV) through regulation of expression of the AAV REP and CAP proteins. The methods and compositions of the invention are based on the observation that the low level expression of the AAV REP protein increases the production of AAV viral capsid protein and efficiency of packaging resulting in production of higher titre recombinant viral stocks. The invention encompasses recombinant AAV vectors that direct the expression of AAV REP and CAP proteins and the use of such vectors for the production of novel stable cell lines capable of generating high titre rAAV vectors. The invention provides methods for regulating the expression of the AAV REP gene at the transcriptional and post-translational level. The methods and compositions of the invention can be used to produce high titre stocks of rAAV which can be used in gene therapy for the purpose of transferring genetic information into appropriate host cells for the management and correction of human diseases including inherited and acquired disorders.
    • 本发明涉及通过调节AAV REP和CAP蛋白的表达来增加重组AAV(rAAV)的高滴度储备的生产的方法和组合物。 本发明的方法和组合基于AAV REP蛋白的低水平表达增加AAV病毒衣壳蛋白的产生和包装效率的观察,导致产生较高滴度的重组病毒种群。 本发明包括引导AAV REP和CAP蛋白的表达的重组AAV载体,以及这些载体用于产生能产生高滴度rAAV载体的新型稳定细胞系的用途。 本发明提供了在转录和翻译后水平调节AAV REP基因表达的方法。 本发明的方法和组合物可用于生产高滴度的rAAV,其可用于基因治疗,以将遗传信息转移到合适的宿主细胞中,用于管理和矫正包括遗传和获得性疾病在内的人类疾病。